Hepatitis E in hemodialysis and kidney transplant patients in South-East Italy

World Journal of Gastroenterology

Volumn 21, Issue 11, 2015, Pages 3266-3273

  Scotto, Gaetano ^a   Aucella, Filippo ^b   Grandaliano, Giuseppe ^a   Martinelli, Domenico ^a   Querques, Mario ^c   Gesuete, Antonio ^b   Infante, Barbara ^a   Delli Carri, Paolo ^c   Massa, Salvatore ^a   Salatino, Giovanna ^c   Bulla, Fabio ^a   Fazio, Vincenzina ^c  

^a UNIVERSITY OF FOGGIA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c Hospital of Foggia   (Italy)

Author keywords

Hemodialysis patients; Hepatitis E virus infection; Immunosuppressed subjects; Prevalence; Transplant recipients

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA; BIOLOGICAL MARKER; HEPATITIS ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; END STAGE RENAL DISEASE; ENZYME IMMUNOASSAY; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; ITALY; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROPREVALENCE; WESTERN BLOTTING; ADVERSE EFFECTS; BLOOD; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; GENOTYPE; HEPATITIS, CHRONIC; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MULTICENTER STUDY; ODDS RATIO; PREVALENCE; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL;

BIOMARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ITALY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 84925605716     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i11.3266     Document Type: Article

References (58)

1. Tsianos EV, Dalekos GN, Elisaf M, Zervou E, Siamopoulos KC. High frequency of antibodies to Hantaan virus and hepatitis C virus in chronic haemodialysis patients. Coincidence or cross-reaction? J Intern Med 1993;234:607-610 [PMID: 8258753 DOI: 10.1111/j.1365-2796.1993.tb01021.x]
2. Fabrizi F, Lunghi G, Martin P. Hepatitis B virus infection in hemodialysis: recent discoveries. J Nephrol 2002;15:463-468 [PMID: 12455711 DOI: 10.1111/j.1525-139x.2007.00311.x]
3. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002;36:3-10 [PMID: 12085342 DOI: 10.1053/jhep. 2002.34613]
4. Wong PN, Fung TT, Mak SK, Lo KY, Tong GM, Wong Y, Loo CK, Lam EK, Wong AK. Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol 2005;20:1641-1651 [PMID: 16246180 DOI: 10.1111/j.1440-1746.2005.03837.x]
5. Mina P, Georgiadou SP, Rizos C, Dalekos GN, Rigopoulou EI. Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol 2010;16:225-231 [PMID: 20066742 DOI: 10.3748/wjg.v16.i2.225]
6. Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986;153:1149-1151 [PMID: 3701120 DOI: 10.1093/infdis/153.6.1149]
7. Ayoola EA, Huraib S, Arif M, Al-Faleh FZ, Al-Rashed R, Ramia S, Al-Mofleh IA, Abu-Aisha H. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. J Med Virol 1991;35:155-159 [PMID: 1725179 DOI: 10.1002/jmv. 1890350303]
8. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992;19:345-352 [PMID: 1562024 DOI: 10.1016/s0272-6386 (12) 80452-5]
9. Okuda K, Hayashi H, Yokozeki K, Kobayashi S, Kashima T, Irie Y. Acute hepatitis C among renal failure patients on chronic haemodialysis. J Gastroenterol Hepatol 1998;13:62-67 [PMID: 9737574 DOI: 10.1111/j.1440-1746.1998.tb00547.x]
10. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709 [PMID: 18992406 DOI: 10.1016/s1473-3099 (08) 70255-x]
11. Scotto G, Martinelli D, Centra M, Querques M, Vittorio F, Delli Carri P, Tartaglia A, Campanale F, Bulla F, Prato R, Fazio V. Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy). Epidemiol Infect 2014;142:287-294 [PMID: 23673019 DOI: 10.1017/s0950268813001167]
12. Dalekos GN, Zervou E, Elisaf M, Germanos N, Galanakis E, Bourantas K, Siamopoulos KC, Tsianos EV. Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit. Transfusion 1998;38:589-595 [PMID: 9661693 DOI: 10.1046/j.1537-2995.1998.38698326339.x]
13. Stefanidis I, Zervou EK, Rizos C, Syrganis C, Patsidis E, Kyriakopoulos G, Sdrakas L, Tsianas N, Rigopoulou EI, Liakopoulos V, Dalekos GN. Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece. Int J Artif Organs 2004;27:842-847 [PMID: 15560678 DOI: 10.1016/j.jcv. 2005.05.007]
14. Sylvan SP, Jacobson SH, Christenson B. Prevalence of antibodies to hepatitis E virus among hemodialysis patients in Sweden. J Med Virol 1998;54:38-43 [PMID: 9443107 DOI: 10.1002/(sici) 1096-9 071 (199801) 54]
15. Mitsui T, Tsukamoto Y, Hirose A, Suzuki S, Yamazaki C, Masuko K, Tsuda F, Endo K, Takahashi M, Okamoto H. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J Med Virol 2006;78:1015-1024 [PMID: 16789007 DOI: 10.1002/jmv. 20657]
16. Litjens NH, Huisman M, Van Den Dorpel M, Betjes MG. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol 2008;19:1483-1490 [PMID: 18480314 DOI: 10.1681/asn. 2007090971]
17. Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrology (Carlton) 2010;15:137-145 [PMID: 20470270 DOI: 10.1111/j.1440-1797.2009.01268.x]
18. Cohen G, Haag-Weber M, Hörl WH. Immune dysfunction in uremia. Kidney Int Suppl 1997;62:S79-S82 [PMID: 9350688 DOI: 10.3390/toxins4110962]
19. Reuter G, Fodor D, Forgách P, Kátai A, Szucs G. Characterization and zoonotic potential of endemic hepatitis E virus (HEV) strains in humans and animals in Hungary. J Clin Virol 2009;44:277-281 [PMID: 19217346 DOI: 10.1016/j.jcv. 2009.01.008]
20. Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, Purcell RH. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008;47:1026-1031 [PMID: 18781880 DOI: 10.1086/591970]
21. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002;40:117-122 [PMID: 11773103 DOI: 10.1128/jcm.40.1.117-122.2002]
22. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008;80:646-658 [PMID: 18297720 DOI: 10.1002/jmv. 21116]
23. Somani SK, Aggarwal R, Naik SR, Srivastava S, Naik S. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J Viral Hepat 2003;10:446-449 [PMID: 14633178 DOI: 10.1046/j.1365-2893.2003.00458.x]
24. Teshale EH, Grytdal SP, Howard C, Barry V, Kamili S, Drobeniuc J, Hill VR, Okware S, Hu DJ, Holmberg SD. Evidence of persontoperson transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2010;50:1006-1010 [PMID: 20178415 DOI: 10.1086/651077]
25. Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, Scobie L, Petrik J. Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105:283-289 [PMID: 23763589 DOI: 10.1111/vox.12056]
26. Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-2312 [PMID: 22172156 DOI: 10.3201/eid1712.110371]
27. Scotto G, Giammario A, Centra M, Vittorio F, Martinelli D, Fazio V. Seroprevalence of hepatitis E virus among blood donors in a district of southern Italy. Blood Transfus 2012;10:565-566 [PMID: 22682344 DOI: 10.2450/2012.0154-11]
28. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, Takahashi M, Nishizawa T, Okamoto H. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004;74:563-572 [PMID: 15484278 DOI: 10.1002/jmv. 20215]
29. Kikuchi K, Yoshida T, Kimata N, Sato C, Akiba T. Prevalence of hepatitis E virus infection in regular hemodialysis patients. Ther Apher Dial 2006;10:193-197 [PMID: 16684223 DOI: 10.1111/j.1744-9987.2006.00363.x]
30. Psichogiou M, Vaindirli E, Tzala E, Voudiclari S, Boletis J, Vosnidis G, Moutafis S, Skoutelis G, Hadjiconstantinou V, Troonen H, Hatzakis A. Hepatitis E virus (HEV) infection in haemodialysis patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1996;11:1093-1095 [PMID: 8671974 DOI: 10.1093/oxfordjournals.ndt.a027461]
31. Ibarra H, Riedemann S, Reinhardt G, Ardiles L, Calvo M, Siegel F. Anti-HEV in dialysis and renal transplant patients in an endemic region in Chile. Clin Nephrol 1998;50:267-268 [PMID: 9799076 DOI: 10.1016/s0140-6736 (94) 90315-8]
32. Buffet C, Laurent-Puig P, Chandot S, Laurian Y, Charpentier B, Briantais MJ, Dussaix E. A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations. J Hepatol 1996;24:122-125 [PMID: 8834035 DOI: 10.1016/s0168-8278 (96) 80196-6]
33. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811-817 [PMID: 18287603 DOI: 10.1056/nejmoa0706992]
34. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008;358:859-860 [PMID: 18287615 DOI: 10.1056/nejmc0708687]
35. Gérolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009;50:622-624 [PMID: 19157619 DOI: 10.1016/j.jhep. 2008.12.008]
36. Haagsma EB, Van Den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008;14:547-553 [PMID: 18383084 DOI: 10.1002/lt.21480]
37. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, Nicand E. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009;150:430-431 [PMID: 19293084 DOI: 10.7326/0003-4819-150-6-200903170-00026]
38. Péron JM, Mansuy JM, Récher C, Bureau C, Poirson H, Alric L, Izopet J, Vinel JP. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006;21:1223-1224 [PMID: 16824086 DOI: 10.1111/j.1440-1746.2006.04209.x]
39. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, Mishiro S, Shimizu K, Moriyama M. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37:113-120 [PMID: 17300706 DOI: 10.1111/j.1872-034x.2007.00024.x]
40. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025-1027 [PMID: 19726781 DOI: 10.1056/nejmc0903778]
41. Gouvea V, Hoke CH, Innis BL. Genotyping of hepatitis E virus in clinical specimens by restriction endonuclease analysis. J Virol Methods 1998;70:71-78 [PMID: 9506814 DOI: 10.1016/s0166-0934 (97) 00172-9]
42. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503 [PMID: 18192058 DOI: 10.1016/j.jhep. 2007.12.008]
43. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009;24:1484-1493 [PMID: 19686410 DOI: 10.1111/j.1440-1746.2009.05933.x]
44. Gessoni G, Manoni F. Hepatitis E virus infection in north-east Italy: serological study in the open population and groups at risk. J Viral Hepat 1996;3:197-202 [PMID: 8871881 DOI: 10.1111/j.1365-2893.1996.tb00095.x]
45. Fabrizi F, Lunghi G, Bacchini G, Corti M, Pagano A, Locatelli F. Hepatitis E virus infection in haemodialysis patients: a seroepidemiological survey. Nephrol Dial Transplant 1997;12:133-136 [PMID: 9027787 DOI: 10.1093/ndt/12.1.133]
46. Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, Vischi F, Alric L, Vinel JP, Izopet J. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004;74:419-424 [PMID: 15368508 DOI: 10.1002/jmv. 20206]
47. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799-805 [PMID: 20336757 DOI: 10.1002/jmv. 21656]
48. Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N, Dimitrova Z, Kamili S, Teo CG. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010;51:e24-e27 [PMID: 20578874 DOI: 10.1086/654801]
49. Haqshenas G, Huang FF, Fenaux M, Guenette DK, Pierson FW, Larsen CT, Shivaprasad HL, Toth TE, Meng XJ. The putative capsid protein of the newly identified avian hepatitis E virus shares antigenic epitopes with that of swine and human hepatitis E viruses and chicken big liver and spleen disease virus. J Gen Virol 2002;83:2201-2209 [PMID: 12185274]
50. Ayoola EA, Want MA, Gadour MO, Al-Hazmi MH, Hamza MK. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J Med Virol 2002;66:329-334 [PMID: 11793384 DOI: 10.1002/jmv. 2149]
51. Chauhan A, Jameel S, Dilawari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer. Lancet 1993;341:149-150 [PMID: 8093748 DOI: 10.1016/0140-6736 (93) 9000 8-5]
52. Harrison A, Scobie L, Crossan C, Parry R, Johnston P, Stratton J, Dickinson S, Ellis V, Hunter JG, Prescott OR, Madden R, Lin NX, Henley WE, Bendall RP, Dalton HR. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol 2013;85:266-271 [PMID: 23169048 DOI: 10.1002/jmv. 23463]
53. Jaques LB, Kavanagh LW, Kuo SH. Variation in commercial heparin and its relation to the problem of heparin standardization for clinical use. Thromb Res 1973;3:295-306 [DOI: 10.1016/0049-384 8 (73) 90055-8]
54. Lee YH, Ha Y, Ahn KK, Chae C. Localisation of swine hepatitis E virus in experimentally infected pigs. Vet J 2009;179:417-421 [PMID: 18308595 DOI: 10.1016/j.tvjl.2007.10.028]
55. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 2001;38:1009-1015 [PMID: 11684554 DOI: 10.1053/ajkd.2001.28590]
56. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011;17:30-37 [PMID: 21192851 DOI: 10.3201/eid1701.100527]
57. Luo H, Chen H, Daloze P, Chang JY, St-Louis G, Wu J. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation 1992;53:1071-1076 [PMID: 1585470 DOI: 10.1097/00007890-199205000-00019]
58. Aagaard-Tillery KM, Jelinek DF. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol 1994;156:493-507 [PMID: 7517796 DOI: 10.1006/cimm.1994.1193]